9 related news articles for Cell Death and Inflammatory Signalling

A/Prof Lawlor leads the Cell Death and Inflammatory Signalling Group that investigates the intricate links between cell death and inflammation and how these processes impact various inflammatory and infectious diseases. …  Read more

Inflammation is at the heart of numerous diseases and new research has found that the exact time an innate immune cell dies is crucial to the inflammatory process.…  Read more

Keeping T cells active, but not too active, could be the key to new potential immune therapies, according to the latest research.…  Read more

Chronic or acute inflammation can contribute to a range of ailments – some potentially deadly – including stroke, respiratory and heart disease, cancer, arthritis, asthma, dementia, multiple sclerosis, and diabetes.…  Read more

A two-day workshop is being held to promote collaborative research opportunities between cancer and inflammation researchers at Hudson Institute and the Department of Immunology at the University of Toronto.…  Read more

Hudson Institute has had outstanding success in the NHMRC Ideas Grant round.

Our researchers have been awarded nine NHMRC Ideas Grants, totalling almost $8.5 million and a success rate of 19.1 per cent.…  Read more

Dr Kate Lawlor has been awarded a prestigious ARC Future Fellowship to further her research into cell death.…  Read more

The discovery of how some cancer drugs can deliver a ‘double-hit’ when targeting tumour cells could lead to further advancements in treatment. A new study has challenged the long-held belief that a type of induced cell death, which is regulated by the BCL-2 family of proteins, attacks cells in only one way. The findings published…  Read more

Hudson Institute has had excellent success in the recent NHMRC and ARC Grant rounds.…  Read more